Didanosine and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported as a side effect among people who take Didanosine (didanosine), especially for people who are male, 40-49 old, have been taking the drug for 6 - 12 months also take Lamivudine, and have Burkitt's lymphoma.

The phase IV clinical study analyzes which people have Bleeding disorders when taking Didanosine. It is created by eHealthMe based on reports of 7,437 people who have side effects when taking Didanosine from the FDA, and is updated regularly.

What is Didanosine?

Didanosine has active ingredients of didanosine. It is often used in hiv infection. eHealthMe is studying from 7,446 Didanosine users. Check the latest studies of Didanosine.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,197 drugs and 1,648 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

On Jul, 05, 2026

7,437 people reported to have side effects when taking Didanosine.
Among them, 15 people (0.2%) have Bleeding disorders.

Could Didanosine cause Bleeding disorders?

Among these 15 people:

How long have people been on Didanosine when they have Bleeding disorders? *

What is the gender of people who have Bleeding disorders when taking Didanosine? *

female: 20 %
male: 80 %

What is the age of people who have Bleeding disorders when taking Didanosine? *

What are other drugs people take besides Didanosine? *

What are other side effects people have besides Bleeding disorders? *

Hepatic Failure (liver failure): 8 people, 53.33%
Haemorrhage (bleeding): 7 people, 46.67%
Ascites (accumulation of fluid in the abdominal cavity): 6 people, 40.00%
Fever: 5 people, 33.33%
Encephalopathy (functioning of the brain is affected by some agent or condition): 5 people, 33.33%
Hypotension (abnormally low blood pressure): 5 people, 33.33%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 26.67%
Hepatomegaly (abnormal enlargement of the liver): 4 people, 26.67%
Acute Kidney Failure: 4 people, 26.67%
Anaemia (lack of blood): 3 people, 20.00%

What are the existing conditions these people have? *

Burkitt's Lymphoma (cancer of the lymphatic system): 3 people, 20.00%
Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 2 people, 13.33%
Hiv Test Positive: 2 people, 13.33%
Hepatitis C: 2 people, 13.33%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 13.33%
Pneumonia: 1 person, 6.67%
Insomnia (sleeplessness): 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Didanosine and have Bleeding disorders?

- Check whether Bleeding disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Didanosine:

Didanosine (7,446 reports)

Browse all side effects of Didanosine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding disorders:

Bleeding disorders (1,197 drugs)

Browse all the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,648 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on didanosine (the active ingredients of Didanosine) and Didanosine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.